2.44
price down icon2.79%   -0.07
after-market After Hours: 2.48 0.04 +1.64%
loading

Editas Medicine Inc Stock (EDIT) Forecast

The Editas Medicine Inc (EDIT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.18, representing a +685.99% increase from the current price of $2.44. The highest analyst price target is $24.77, and the lowest is $13.58.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EDIT Price Target
Average 49.16 (+1,915% Upside)
loading

Is Editas Medicine Inc (EDIT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 43.06 Neutral
STOCH(9,6) 17.86 Buy
STOCHRSI(14) 17.53 Buy
MACD(12,26) 0.0772 Sell
ADX(14) 38.32 Sell
William %R -94.21 Buy
CCI(14) -113.60 Sell
Buy: 3 Sell: 3 Neutral: 1
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
2.94
Sell
2.7511
Sell
MA20
2.8875
Sell
2.7482
Sell
MA50
2.3642
Buy
2.4394
Buy
MA100
1.8684
Buy
2.1852
Buy
MA200
1.9458
Buy
2.5032
Sell
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, EDIT could be considered a Neutral, with 17 technical analysis indicators signaling 8 Buy signals, 8 signaling Sell signals and 1 Neutral signals. This suggests that investors should exercise caution when entering new positions on EDIT, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 43.06 indicates that EDIT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 17.86 indicates that EDIT is oversold. This indicates that EDIT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.53 indicates that EDIT is oversold. This suggests that EDIT price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 38.32 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -113.6 indicates that EDIT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term EDIT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Editas Medicine Inc financial reports and earnings history, Editas Medicine Inc (EDIT) stock could reach $15.36 by 2030, $15.11 by 2040 and $36.12 by 2050. See the projected annual prices until 2050 of the Editas Medicine Inc stock below:

  • Editas Medicine Inc (EDIT) is expected to reach an average price of $0.6512 in 2035, with a high prediction of $4.796 and a low estimate of $1.4212. This indicates an $-73.31% rise from the last recorded price of $2.44.
  • Editas Medicine Inc (EDIT) stock is projected to chart a bullish course in 2040, with an average price target of $13.72, representing an $462.28% surge from its current level. The forecast ranges from a conservative $14.23 to a sky-high $15.11.
  • Our analysts predict Editas Medicine Inc (EDIT) to jump 870.72% by 2045, soaring from $22.09 to an average price of $23.69, potentially reaching $22.74. While $22.09 is the low estimate, the potential upside is significant.
  • Editas Medicine Inc (EDIT) stock is expected to climb by 2050, reaching an average of $34.39, a $1,309% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.12 and $36.98, respectively, highlighting the market's uncertainty.

Editas Medicine Inc Stock (EDIT) Year by Year Forecast

Editas Medicine Inc Stock (EDIT) Price Forecast for 2025

Editas Medicine Inc Stock (EDIT) is expected to reach an average price of $12.58 in 2025, with a high prediction of $24.77 and a low estimate of $0.3883. This indicates an +415.59% rise from the last recorded price of $2.44.
Month Average Low High Change from today's price
September, 2025 $19.52 $13.58 $24.77 +700.10%
October, 2025 $15.53 $13.57 $23.13 +536.44%
November, 2025 $13.32 $12.95 $19.24 +445.76%
December, 2025 $16.44 $12.32 $20.46 +573.90%

Editas Medicine Inc Stock (EDIT) Price Forecast for 2026

The predicted value for Editas Medicine Inc (EDIT) in 2026 is set at an average of $49.33. Estimates vary from a peak of $86.00 to a trough of $12.67, indicating an +1,922% surge from the present price of $2.44.
Month Average Low High Change from today's price
January, 2026 $17.04 $12.67 $18.48 +598.38%
February, 2026 $50.30 $15.59 $53.58 +1,961%
March, 2026 $62.24 $48.27 $86.00 +2,451%
April, 2026 $42.83 $39.09 $63.04 +1,655%
May, 2026 $31.54 $22.54 $42.64 +1,193%
June, 2026 $26.20 $23.78 $35.76 +973.64%
July, 2026 $20.20 $16.33 $30.22 +728.01%
August, 2026 $24.60 $18.88 $25.77 +908.23%
September, 2026 $36.00 $20.38 $47.38 +1,375%
October, 2026 $43.11 $25.21 $44.50 +1,667%
November, 2026 $51.41 $44.25 $56.13 +2,007%
December, 2026 $29.12 $27.68 $60.90 +1,093%

Editas Medicine Inc Stock (EDIT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Editas Medicine Inc (EDIT) is $15.29, with a high forecast of $30.52 and a low forecast of $0.0638. This indicates an +526.80% increase from the last price of $2.44.
Month Average Low High Change from today's price
January, 2027 $26.00 $22.55 $29.24 +965.42%
February, 2027 $23.81 $23.52 $30.52 +875.97%
March, 2027 $18.59 $15.53 $24.05 +661.90%
April, 2027 $11.01 $9.8077 $19.64 +351.13%
May, 2027 $7.835 $5.3763 $10.65 +221.11%
June, 2027 $5.4117 $2.503 $9.0844 +121.79%
July, 2027 $8.5691 $3.3204 $10.14 +251.19%
August, 2027 $4.3364 $4.0064 $11.24 +77.72%
September, 2027 $1.6731 $0.0638 $5.7851 -31.43%
October, 2027 $1.4805 $0.2195 $3.5212 -39.32%
November, 2027 $5.3879 $1.1698 $5.8179 +120.81%
December, 2027 $9.4046 $3.5472 $10.60 +285.43%

Editas Medicine Inc Stock (EDIT) Price Forecast for 2028

In 2028, Editas Medicine Inc (EDIT) is projected to reach an average price of $4.7939, with a high projection of $9.5639 and a low estimate of $0.0238. This indicates an +96.47% rise from the last price of $2.44.
Month Average Low High Change from today's price
January, 2028 $5.6619 $4.9319 $9.5639 +132.05%
February, 2028 $3.2693 $3.0793 $7.2713 +33.99%
March, 2028 $3.826 $2.2466 $4.3773 +56.80%
April, 2028 $1.5033 $1.034 $5.5553 -38.39%
May, 2028 $0.56 $0.41 $2.252 -77.05%
June, 2028 $0.0326 $0.0238 $1.0687 -98.66%
July, 2028 $1.8747 $0.1733 $3.9929 -23.17%
August, 2028 $0.1914 $0.1586 $2.5341 -92.15%
September, 2028 $0.5212 $0.0308 $1.1458 -78.64%
October, 2028 $2.5262 $0.2125 $3.2762 +3.53%
November, 2028 $2.6729 $1.7335 $3.5155 +9.54%
December, 2028 $1.4302 $0.8609 $5.0115 -41.38%

Editas Medicine Inc Stock (EDIT) Price Forecast for 2029

The 2029 price forecast for Editas Medicine Inc Stock (EDIT) is $5.8538 on average, with a high prediction of $11.49 and a low estimate of $0.2176. This represents an +139.91% increase from the previous price of $2.44.
Month Average Low High Change from today's price
January, 2029 $2.2269 $1.2496 $2.4889 -8.73%
February, 2029 $2.4143 $1.7956 $3.0163 -1.05%
March, 2029 $2.2316 $2.1316 $3.2816 -8.54%
April, 2029 $1.089 $0.7753 $2.5203 -55.37%
May, 2029 $1.9557 $0.2176 $3.3457 -19.85%
June, 2029 $5.2531 $1.485 $5.6437 +115.29%
July, 2029 $4.8104 $4.2825 $6.2224 +97.15%
August, 2029 $1.9571 $1.8771 $5.0898 -19.79%
September, 2029 $2.9345 $1.8565 $3.5551 +20.27%
October, 2029 $2.8412 $2.8112 $6.7538 +16.44%
November, 2029 $1.0585 $0.8535 $3.0155 -56.62%
December, 2029 $13.27 $0.7279 $11.49 +443.85%

Editas Medicine Inc Stock (EDIT) Price Forecast for 2030

Editas Medicine Inc Stock (EDIT) is expected to reach an average price of $9.3434 in 2030, with a high forecast of $15.36 and a low forecast of $3.3228. This signifies an +282.93% surge from the last price of $2.44.
Month Average Low High Change from today's price
January, 2030 $15.11 $15.52 $15.36 +519.12%
February, 2030 $11.71 $13.03 $13.33 +380.00%
March, 2030 $11.20 $11.41 $10.92 +358.84%
April, 2030 $11.16 $11.83 $10.87 +357.48%
May, 2030 $12.58 $10.72 $12.31 +415.53%
June, 2030 $13.94 $13.96 $14.27 +471.33%
July, 2030 $10.18 $11.91 $13.01 +317.25%
August, 2030 $2.1662 $3.8912 $3.7623 -11.22%
September, 2030 $2.8515 $3.5775 $3.8702 +16.86%
October, 2030 $6.2881 $3.3228 $4.9381 +157.71%
November, 2030 $14.41 $8.3894 $9.9634 +490.71%
December, 2030 $12.99 $13.22 $11.88 +432.32%
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):